Innovative microalgae specialist TerraVia acquired by Corbion
(Thomson Reuters ONE) -
Corbion today announced the completion of the acquisition of substantially all
assets of TerraVia Holdings ("TerraVia"). As a result, its broad and diverse
platform centered on innovative food and specialty ingredients derived from
microalgae, has now become part of Corbion.
Corbion has paid a cash purchase price of approximately US$ 20 million. Corbion
expects the total investments to be substantially in excess of the cash purchase
price. TerraVia's operations are currently loss making. The acquisition is
expected to bring high value creation potential.
Tjerk de Ruiter, CEO of Corbion: "We are looking forward to welcoming a team of
highly dedicated colleagues to the global Corbion family. TerraVia brings us a
versatile microalgae-based platform which will enable us to expand into the
field of producing specialty lipids and proteins, structured fats and tailored
oils. TerraVia's IP portfolio and R&D pipeline, as well as its partnerships with
industry leaders, provide high-growth opportunities for many years to come. At
the same time, we are of course aware of the challenge of bringing the business
from promise to commercial success. Corbion's more than 80 years of reliably and
economically running industrial-scale fermentation plants and producing
sustainable ingredient solutions will help us turn the TerraVia assets into
profitable businesses in the coming years."
San Francisco-based TerraVia leverages its microalgae platform to deliver high-
value ingredients with clear benefits, such as Omega-3 oils for animal nutrition
and tailored oils, structured fats and proteins for food, personal care and
industrial applications. It operates an R&D center and pilot facility in
San Francisco, a demonstration plant in Peoria (Illinois) and an industrial
scale plant in Brazil in a joint venture (50.1% owned by TerraVia) with Bunge.
Financial guidance
* The acquisition is expected to enhance Corbion's long term pro-forma(1)
sales growth by 100bps p.a.
* Operating expenses (S, G&A and R&D combined): More than 50% reduction in
2018 compared to TerraVia levels reported in 2016(2)
* Pro-forma(1) EBITDA expected to be positive from 2020 onwards
* EBITDA impact: negative in 2017 and coming years due to high R&D intensity,
while majority of short term revenue generating capacity is recorded in
unconsolidated(3) SB Oils joint venture (50.1% ownership)
* EBITDA impact is expected to be max. US$ -25M per annum in the coming
years
* EBITDA impact range for 2017: US$ -7M to -12M
* As 50.1% owner of the SB Oils joint venture, Corbion will also guarantee
half of the US$ 45M outstanding debt
* Expected max. adverse impact on Net Debt/EBITDA ratio: increase by 0.5 -
0.7 x
(1) Pro-forma net sales and EBITDA includes Corbion's reported net sales and
EBITDA and 50.1% of unconsolidated SB Oils joint venture net sales and EBITDA
(2) TerraVia SEC 10K filing 2016, p.62
(3) SB Oils joint venture will be accounted for via equity method. 50.1% of
joint venture net income will be recorded in Results from joint ventures and
associates
A conference call for investors and analysts is scheduled for Friday, 29
September 2017 at 15:00 CET. For dial-in details please contact Jeroen van
Harten, Investor Relations (see below).
This press release contains inside information within the meaning of Article
7(1) of the EU Market Abuse Regulation.
For more information, please contact:
Analysts and investors:
Jeroen van Harten, Director Investor Relations
+31 (0)20 590 6293, +31(0)6 2157 7086
Press:
Tanno Massar, Director Corporate Communications
+31 (0)20 590 6325, +31 (0)6 1158 9121
Background information:
Corbion is the global market leader in lactic acid and lactic acid derivatives,
and a leading company in emulsifiers, functional enzyme blends, minerals and
vitamins. We develop sustainable solutions to improve the quality of life for
people today and generations to come. For over 100 years, we have been
uncompromising in our commitment to safety, quality and performance. Drawing on
our deep application and product knowledge, we work side-by-side with customers
to make our cutting-edge technologies work for them. Our solutions help
differentiate products in markets such as food, home & personal care,
pharmaceuticals, medical devices and bioplastics. In 2016, Corbion generated
annual sales of ? 911.3 million and had a workforce of 1,684 FTE. Corbion is
listed on Euronext Amsterdam. For more information: www.corbion.com
20170929 TVIA COMPLETION ENG-FINAL:
http://hugin.info/160089/R/2137800/818348.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Corbion via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 29.09.2017 - 07:00 Uhr
Sprache: Deutsch
News-ID 561837
Anzahl Zeichen: 5558
contact information:
Town:
Amsterdam
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 312 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Innovative microalgae specialist TerraVia acquired by Corbion"
steht unter der journalistisch-redaktionellen Verantwortung von
Corbion (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
